• In the media
  • Goede antiresistentie-maatregelen farmaceut m...
Media - published on 23 Jan 2018

Goede antiresistentie-maatregelen farmaceut moet concurrent inspireren

NOS takes a look at the Antimicrobial Resistance Benchmark and the current TB landscape in the Netherlands.

This article focuses on the topic of antibiotic resistance in the Netherlands. It highlights the findings of the Antimicrobial Resistance Benchmark relating to pharmaceutical company activities in R&D, in antibiotic manufacturing, in AMR surveillance and responsible promotion.

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |